G1 Therapeutics, Inc.
GTHX · NASDAQ
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $15 | $20 | $32 | $94 |
| Short-Term Investments | $46 | $45 | $50 | $0 |
| Receivables | $13 | $12 | $13 | $9 |
| Inventory | $13 | $13 | $12 | $13 |
| Other Curr. Assets | $6 | $6 | $8 | $9 |
| Total Curr. Assets | $93 | $96 | $115 | $126 |
| Property Plant & Equip (Net) | $6 | $6 | $6 | $7 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $6 | $6 | $7 | $7 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $99 | $102 | $122 | $133 |
| Liabilities | – | – | – | – |
| Payables | $5 | $5 | $4 | $7 |
| Short-Term Debt | $11 | $6 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $1 | $0 | $1 | $1 |
| Other Curr. Liab. | $20 | $21 | $25 | $26 |
| Total Curr. Liab. | $38 | $33 | $30 | $34 |
| LT Debt | $37 | $41 | $56 | $56 |
| Deferred Rev, NC | $0 | $1 | $1 | $1 |
| Deferred Tax Liab, NC | $0 | $4 | $4 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $37 | $42 | $56 | $56 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $4 | $4 | $4 | $5 |
| Total Liabilities | $74 | $74 | $86 | $90 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$796 | -$790 | -$780 | -$769 |
| AOCI | $0 | -$0 | -$0 | -$0 |
| Other Equity | $820 | $818 | $815 | $812 |
| Total Equity | $25 | $28 | $35 | -$769 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $99 | $102 | $122 | -$679 |
| Net Debt | $33 | $27 | $24 | -$38 |